
Policy and Politics


Research looks at opportunities for growth in cannabis sector…
26th May 2022 - Alerts | Australasia, Australia |

President ratifies cannabis legalisation bill…
25th May 2022 - Alerts | Argentina, South America |


Clustering of cannabis shops becomes an election issue in Ontario…
23rd May 2022 - Alerts | Canada, North America |

What action in the name of sustainability is the CBD industry likely to see?
19th May 2022 - Blog , Business briefing |
CBD is already working from a higher base than many consumer products on the market. But that does not mean there is nothing else to be done


Psychedelics and mental health research: hope for public and policy support
27th April 2022 - Business briefing |
Jamaica is attempting to make itself as synonymous with medical-grade psychedelics in the minds of researchers as it is with cannabis production in the minds of many

Home Office states its position on cannabis and drug policy…
21st April 2022 - Alerts | Europe, United Kingdom |

Industry bodies optimistic UK regulators will take Hodges Review on board
20th April 2022 - Business briefing |
Industry associations hope a review of UK policy on cannabinoids will help the government address regulation that has limited the development of the CBD and wider sectors

Argentine bill to establish legal cannabis industry set to be passed ‘within weeks’
14th April 2022 - Regulatory briefing |
Argentina’s Chamber of Deputies is expected to approve a bill creating a legal framework for the cultivation, manufacture and sale of medicinal cannabis and hemp “within two months”, CBD-Intel has been told


Vice-president speaks up for legalisation of medical cannabis…
12th April 2022 - Alerts | Central America, Honduras |

Canada’s cannabis industry welcomes a federal budget full of good things
11th April 2022 - Regulatory briefing |
Canada’s cannabis trade is celebrating after the government tabled a budget calling for steps to streamline a variety of tax measures and launch a strategy group to examine ways to grow the industry

So far so good, but German lawmakers urged to go further on medical cannabis
11th April 2022 - Regulatory briefing |
Five years after German patients were first allowed to obtain medical cannabis, demand has risen sharply – but there are still some unanswered issues on policy and practice that lobbyists want addressed

Argentina’s president and development minister back cannabis framework
7th April 2022 - Regulatory briefing |
Argentina’s president is urging the national Congress to approve a law this year that would establish a legal framework for the production and sale of medicinal cannabis and industrial hemp

Bid to block cannabis sales trial before it begins…
7th April 2022 - Alerts | Europe, Switzerland |

Long trips for a short supply, but there’s optimism in Iowa on medical cannabis
6th April 2022 - Regulatory briefing |
Patients in Iowa who rely on supplies of medical cannabis are tightly restricted in how much they can have, and may face a long trip to get it from one of the few licensed dispensaries in the US state

House passes Medical Marijuana Research Act…
5th April 2022 - Alerts | North America, United States |

People vs politics – Wisconsin remains divided over what to do about cannabis
4th April 2022 - Regulatory briefing |
Lawmakers in the US state of Wisconsin are sympathetic to patients who could benefit from medical cannabis – but they don’t want to go against federal law

House passes MORE Act…
4th April 2022 - Alerts | North America, United States |

Disappointment across US after CBD language dropped from omnibus bill
29th March 2022 - Regulatory briefing |
CBD stakeholders hoping for clarity in US regulations were left disappointed by the passing of the $1.5tn omnibus spending bill earlier this month as some helpful language was dropped during the final negotiations




Poland set to grow cannabis for medical use after Senate ratifies hemp bill
15th March 2022 - Regulatory briefing |
The Polish Senate has passed a bill introducing new regulations on hemp growing and medical cannabis with minimal changes from the version already approved by the lower parliamentary chamber, the Sejm



New York’s new law could offer some liberty for local hemp producers
4th March 2022 - Business briefing |
Hemp companies are poised to benefit from a new law in New York put forward to help ease supply issues that often occur when a state opens up a legal recreational cannabis market

Regulatory report: Central America, March 2022
4th March 2022 - Regulatory reports |
Covers: Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, Panama. Overall, the region is restrictive on hemp and cannabis, with exceptions being Belize, Costa Rica and Panama

Virginia bill could pose significant threat to CBD products in the state
3rd March 2022 - Regulatory briefing |
A bill originally aimed at restricting the shapes that edible cannabis products may take has morphed into a potential significant threat to CBD products in Virginia

Financial credits for medicinal cannabis manufacturers…
25th February 2022 - Alerts | Colombia, South America |


Italian Constitutional Court rejects referendum on decriminalising cannabis
25th February 2022 - Regulatory briefing |
An Italian referendum on the potential decriminalisation of cannabis for personal use has been rejected by the country’s Constitutional Court

Mississippi medical cannabis bill finally becomes law
25th February 2022 - Regulatory briefing |
Mississippi has finally signed a medical cannabis bill into law after a long and often arduous process.



President’s medical cannabis veto accepted…
17th February 2022 - Alerts | Costa Rica, South America |



President promises 130,000 cannabis jobs…
15th February 2022 - Alerts | Africa, South Africa |

Senate moves on medical cannabis…
15th February 2022 - Alerts | North America, United States, Virginia |

Senate chief refuses legalisation bid…
15th February 2022 - Alerts | North America, Ohio, United States |

South American legislation on cannabis and hemp will progress, if slowly, in 2022
8th February 2022 - Regulatory briefing |
This is an important year for positive legislation affecting cannabinoids across South America, though some depends on election results and all of it will take a few years to take effect

Costa Rica’s president promises to get cannabis legalisation done despite veto
7th February 2022 - Regulatory briefing |
Costa Rican president Carlos Alvarado, who has supported the legalisation of cannabis throughout his administration, has partially vetoed a bill that would have legalised medicinal cannabis and industrial hemp

Early research shows some cannabinoids can prevent Covid-19 infecting cells
3rd February 2022 - Business briefing |
Research from scientists at the University of Oregon suggests that certain cannabinoids can stop the SARS-CoV-2 (Covid-19) virus from infecting cells. This may lead to future treatments

French government defeated in court as hemp flower sales ban is suspended
27th January 2022 - Regulatory briefing |
France’s highest administrative court has temporarily and partially suspended the French decree banning the sale and consumption of CBD hemp flowers

US lawsuits end DEA restrictions on sources of cannabis for researchers
26th January 2022 - Regulatory briefing |
Lawsuits in the US have finally overturned the DEA’s requirement that researchers interested in studying cannabis could only purchase from one source, the University of Mississippi

Italian hemp farm aid and research grants fail to win over the industry
21st January 2022 - Business briefing |
€3m in aid has been allocated to the hemp supply chain following a decree by minister of agriculture Stefano Patuanelli issued in late December 2021

Polish Sejm drafts laws to govern hemp farming for medical applications
20th January 2022 - Regulatory briefing |
A bill governing growing and harvesting of hemp for pharmaceuticals has been passed to the Sejm’s Health Commission and the Agriculture and Rural Development Commission